US2006062772A1PendingUtilityA1
Polypeptide delivery system
Est. expiryOct 16, 2018(expired)· nominal 20-yr term from priority
A61P 43/00A61P 5/02A61P 37/04A61P 3/00A61K 38/27A61K 48/00C12N 15/85C12N 15/63
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An expression construct is disclosed which is useful for delivering an exogenous polypeptide (e.g. a growth hormone such as somatotropin) to a host. In one application of the invention, the expression construct is introduced into a non-host recombinant cell encapsulated in a semi-permeable membrane for implantation into the host. The semi-permeable membrane inhibits immune surveillance and cell rejection events so that non-host, highly expressing, recombinant cells can be used.
Claims
exact text as granted — not AI-modified1 . An expression cassette including a sequence encoding an insulin secretory signal operably linked to a heterologous sequence encoding a mature form of a polypeptide which is normally secreted.
2 . An expression cassette according to claim 1 , wherein the insulin secretory signal has the amino acid sequence shown as SEQ ID NO:1.
3 . An expression cassette according to claim 1 , wherein the insulin secretory signal is a modified insulin secretory signal which has one or more amino acid modifications of the amino acid sequence shown as SEQ ID NO:1 and has substantially the same biological activity as an insulin secretory signal having the amino acid sequence shown as SEQ ID NO:1.
4 . An expression cassette according to any one of claims 1 to 3 , wherein the heterologous sequence encodes a polypeptide selected from hormones, cytokines, receptor agonists, receptor antagonists, pheromones, and enzymes.
5 . An expression cassette according to claim 4 , wherein the heterologous sequence encodes a cytokine.
6 . A vector including an expression cassette according to claim 1 .
7 . A recombinant cell which includes an expression cassette according to claim 1 .
8 . A recombinant cell according to claim 7 , wherein the cell is a bacterial, yeast, insect or mammalian cell.
9 . A recombinant cell according to claim 8 , wherein the cell is a mammalian cell.
10 . A mammalian cell according to claim 9 , wherein the cell is a rat myoblast (L6) cell.
11 . A method of producing a polypeptide which includes culturing a recombinant cell of claim 7 under conditions enabling the expression and secretion of the polypeptide and optionally isolating the polypeptide.
12 . A capsule for implantation in a host, the capsule including a semi-permeable membrane encapsulating recombinant cells according to claim 9 .
13 . A capsule according to claim 12 , wherein the semi-permeable membrane is an alginate-poly-L-lysine-alginate (APA) membrane.
14 . A method of administering a polypeptide to a host, wherein said method includes administering to the host an expression cassette according to claim 1 .
15 . A method of administering a polypeptide to a host, wherein the method includes implanting in the host a capsule according to claim 12 .
16 . A method according to claim 15 , wherein the host is an animal or human.
17 . A method according to claim 16 , wherein the host is a livestock animal.
18 . A method according to claim 17 , wherein the livestock animal is a pig.Join the waitlist — get patent alerts
Track US2006062772A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.